Data Standards Could Help Wearables Restart Clinical Trials

The COVID-19 pandemic delayed most clinical trials, pushing sponsors to explore remote trials using devices like smartwatches and pulse oximeters. However, inconsistent data across platforms was a major challenge. To move forward, the authors of this article recommend pharma and tech industries collaborate to establish common standards and protocols, ensuring reliable data for effective use of wearables in trials.